XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
http://www.dailyhealthindustry.it/ema-limita-tre-farmaci-uno-e-per-la-sclerosi-multipla-ID7748.html20%Monthly2017-10-31 16:41
http://www.dailyhealthindustry.it/ema-a-milano-pronta-delibera-per-pirellone-nuova-sede-ID7746.html20%Monthly2017-10-31 16:02
http://www.dailyhealthindustry.it/eli-lilly-verzenio-best-in-class-nel-tumore-al-seno-ID7744.html20%Monthly2017-10-31 15:44
http://www.dailyhealthindustry.it/novartis-con-acqusizione-aaa-nuova-pipeline-per-i-tumori-neuroendocrini-ID7742.html20%Monthly2017-10-31 15:13
http://www.dailyhealthindustry.it/pfizer-nuovi-dati-per-rilanciare-le-vendite-di-inflectra-ID7740.html20%Monthly2017-10-31 13:58
http://www.dailyhealthindustry.it/shire-produzione-interna-per-cinryze-angioedema-e-razionalizzazione-degli-impianti-ID7738.html20%Monthly2017-10-31 11:48
http://www.dailyhealthindustry.it/amgen-utili-in-crescita-nel-q3-ID7730.html20%Monthly2017-10-30 17:07
http://www.dailyhealthindustry.it/eli-lilly-da-fda-ok-provvisorio-a-eagle-pharma-per-copia-di-alimta-pemetrexed-ID7728.html20%Monthly2017-10-30 17:46
http://www.dailyhealthindustry.it/novartis-acquisisce-advanced-accelerator-application-ID7726.html20%Monthly2017-10-30 15:45
http://www.dailyhealthindustry.it/msd-un-q3-allinsegna-di-keytruda-e-dellanimal-health-ID7724.html20%Monthly2017-10-31 11:08
http://www.dailyhealthindustry.it/abbvie-humira-ancora-top-selling-da-fda-priority-review-per-elagolix-endometriosi-ID7722.html20%Monthly2017-10-30 11:30
http://www.dailyhealthindustry.it/shire-bene-il-q3-e-gli-investitori-festeggiano-ID7720.html20%Monthly2017-10-30 11:11
http://www.dailyhealthindustry.it/celgene-q3-al-ribasso-e-revisione-previsioni-di-vendita-2020-ID7717.html20%Monthly2017-10-27 14:51
http://www.dailyhealthindustry.it/gilead-q3-condizionato-dai-farmaci-anti-hcv-e-arriva-la-concorrenza-ID7715.html20%Monthly2017-10-27 16:12
http://www.dailyhealthindustry.it/farmaci-primo-ok-per-amazon-nella-distribuzione-ID7712.html20%Monthly2017-10-27 13:21
http://www.dailyhealthindustry.it/tesaro-da-fda-via-libera-ad-antiemetico-per-via-endovenosa-ID7710.html20%Monthly2017-10-27 12:36
http://www.dailyhealthindustry.it/pfizer-consumer-health-lievita-il-prezzo-di-vendita-ID7707.html20%Monthly2017-10-27 12:24
http://www.dailyhealthindustry.it/bayer-effetto-monsanto-sul-q3-vendite-deludenti-ID7704.html20%Monthly2017-10-27 12:08
http://www.dailyhealthindustry.it/aifa-tiene-la-spesa-farmaceutica-convenzionata-quella-ospedaliera-e-diretta-supera-i-4-mld-ID7702.html20%Monthly2017-10-26 17:16
http://www.dailyhealthindustry.it/biogen-parte-studio-affinity-per-opcinumab-ID7698.html20%Monthly2017-10-26 17:04
http://www.dailyhealthindustry.it/takeda-quando-le-ibd-sono-malattie-da-graphic-novel-ID7696.html20%Monthly2017-10-26 15:45
http://www.dailyhealthindustry.it/gsk-con-bexit-dura-test-dei-farmaci-fuori-da-uk-ID7693.html20%Monthly2017-10-26 13:25
http://www.dailyhealthindustry.it/sanofi-rivoluzione-robotica-nelle-linee-di-produzione-ID7691.html20%Monthly2017-10-26 12:59
http://www.dailyhealthindustry.it/pfizer-consumer-health-tre-in-pole-position-ID7689.html20%Monthly2017-10-26 12:42
http://www.dailyhealthindustry.it/ddl-lorenzin-melazzini-ottima-notizia-per-sanita-e-ricerca-ID7686.html20%Monthly2017-10-25 17:12
http://www.dailyhealthindustry.it/ge-healthcare-ecco-il-nuovo-angiografo-mobile-ID7683.html20%Monthly2017-10-25 15:54
http://www.dailyhealthindustry.it/gsk-emma-wamsley-conquisteremo-lhealth-consumer-ID7681.html20%Monthly2017-10-25 15:39
http://www.dailyhealthindustry.it/biogen-il-q3-di-spinraza-confonde-gli-analisti-ID7679.html20%Monthly2017-10-25 14:14
http://www.dailyhealthindustry.it/ebola-il-vaccino-parla-anche-cinese-ID7677.html20%Monthly2017-10-25 13:35
http://www.dailyhealthindustry.it/abbvie-200-mln-di-dollari-per-immunoterapia-nellalzheimer-ID7672.html20%Monthly2017-10-25 12:30
http://www.dailyhealthindustry.it/novartis-q3-salgono-vendite-e-utili-lincognita-alcon-ID7670.html20%Monthly2017-10-25 11:13
http://www.dailyhealthindustry.it/gsk-il-nice-raccomanda-strimvelis-ID7659.html20%Monthly2017-10-24 15:43
http://www.dailyhealthindustry.it/pharma-cancer-moonshot-e-su2c-lamerican-way-per-salire-nella-reputazione-dei-consumatori-ID7656.html20%Monthly2017-10-24 16:25
http://www.dailyhealthindustry.it/sanofi-italia-de-ruty-e-grespigna-a-capo-di-general-medicines-e-zentiva-ID7652.html20%Monthly2017-10-24 13:42
http://www.dailyhealthindustry.it/eli-lilly-restyling-per-la-linea-diabete-ID7650.html20%Monthly2017-10-24 13:09
http://www.dailyhealthindustry.it/astrazeneca-nuove-possibilita-per-bydureon-ID7645.html20%Monthly2017-10-24 16:33
http://www.dailyhealthindustry.it/otsuka-il-punto-sulladpkd-un-convegno-a-roma-ID7642.html20%Monthly2017-10-24 16:24
http://www.dailyhealthindustry.it/novartis-breakthrough-therapy-per-combo-tafinlar-mekinist-melanoma-ID7638.html20%Monthly2017-10-23 15:38
http://www.dailyhealthindustry.it/gsk-con-lok-fda-a-shingrix-sempre-piu-al-vertice-della-classifica-vaccini-ID7636.html20%Monthly2017-10-23 14:43
http://www.dailyhealthindustry.it/msd-in-usa-si-concentra-sulle-malattie-croniche-ID7634.html20%Monthly2017-10-23 13:59
http://www.dailyhealthindustry.it/johnson-stop-alla-produzione-delle-pompe-di-insulina-animas-ID7631.html20%Monthly2017-10-23 16:11
http://www.dailyhealthindustry.it/il-codacons-non-vuole-lema-a-milano-ID7629.html20%Monthly2017-10-23 13:10
http://www.dailyhealthindustry.it/celltrion-remsima-efficace-nella-pibd-pediatrica-ID7627.html20%Monthly2017-10-23 13:00
http://www.dailyhealthindustry.it/msd-a-due-anni-pembrolizumab-raddoppia-la-sopravvivenza-nel-tumore-al-polmone-ID7625.html20%Monthly2017-10-20 16:27
http://www.dailyhealthindustry.it/celgene-abbandona-trial-su-mongersen-malattia-di-chron-ID7623.html20%Monthly2017-10-20 16:10
http://www.dailyhealthindustry.it/pfizer-consumer-health-reckitt-benckiser-cambia-organizzazione-commerciale-per-acquisirla-ID7620.html20%Monthly2017-10-20 13:15
http://www.dailyhealthindustry.it/cina-la-grande-sfida-si-chiama-r-s-ID7617.html20%Monthly2017-10-20 12:26
http://www.dailyhealthindustry.it/roche-positivo-il-q3-ID7615.html20%Monthly2017-10-20 11:13
http://www.dailyhealthindustry.it/novo-nordisk-prepara-il-lancio-di-semaglutide-ID7613.html20%Monthly2017-10-20 11:00
http://www.dailyhealthindustry.it/fondazione-msd-digital-health-al-servizio-dei-pazienti-al-via-il-percorso-formativo-ID7610.html20%Monthly2017-10-19 17:36
http://www.dailyhealthindustry.it/astrazeneca-per-lynparza-priority-review-da-fda-ID7605.html20%Monthly2017-10-19 16:59
http://www.dailyhealthindustry.it/prezzi-farmaci-in-usa-aumento-antitumorali-supera-tasso-inflazione-ID7603.html20%Monthly2017-10-19 15:26
http://www.dailyhealthindustry.it/sede-ema-gentiloni-due-o-tre-citta-insidiano-miano-ID7601.html20%Monthly2017-10-19 16:00
http://www.dailyhealthindustry.it/bms-accelera-per-opdivo-nel-melanoma-ad-alto-rischio-recidiva-ID7595.html20%Monthly2017-10-19 13:08
http://www.dailyhealthindustry.it/almirall-italia-alessandro-cappella-e-il-nuovo-country-manager-ID7592.html20%Monthly2017-10-19 13:32
http://www.dailyhealthindustry.it/gilead-ok-da-fda-a-yescarta-terapia-car-t-per-linfoma-a-grandi-cellule-b-ID7587.html20%Monthly2017-10-19 16:58
http://www.dailyhealthindustry.it/giudice-usa-ribalta-caso-baby-powder-niente-multa-da-72-mln-per-johnson-ID7581.html20%Monthly2017-10-18 16:11
http://www.dailyhealthindustry.it/allergan-giudice-usa-annulla-brevetto-restasis-ID7579.html20%Monthly2017-10-18 15:27
http://www.dailyhealthindustry.it/johnson-q3-remicade-resiste-allattacco-dei-biosimilari-ID7576.html20%Monthly2017-10-18 12:35
http://www.dailyhealthindustry.it/vaccino-anti-cancro-entro-i-prossimi-tre-anni-ID7573.html20%Monthly2017-10-18 12:25
http://www.dailyhealthindustry.it/gilead-riva-vp-delloncologia-sara-il-regista-del-lancio-della-terapia-cart-ID7570.html20%Monthly2017-10-18 10:58
http://www.dailyhealthindustry.it/gsk-in-attesa-dellfda-ok-del-canada-a-vaccino-shingrix-ID7568.html20%Monthly2017-10-18 10:29
http://www.dailyhealthindustry.it/assobiomedica-governance-per-le-imprese-di-dispositivi-medici-ID7566.html20%Monthly2017-10-17 15:32
http://www.dailyhealthindustry.it/pfizer-prima-offerta-per-la-consumer-health-ma-e-debole-ID7564.html20%Monthly2017-10-17 15:14
http://www.dailyhealthindustry.it/bms-nuovo-dati-a-favore-di-opdivo-yervoy-nel-tumore-al-polmone-ID7561.html20%Monthly2017-10-17 14:57
http://www.dailyhealthindustry.it/novo-nordisk-per-review-fda-nessun-rischio-per-il-cuore-ID7559.html20%Monthly2017-10-17 14:14
http://www.dailyhealthindustry.it/farmaci-in-italia-brevetti-in-scadenza-per-un-risparmio-di-400-milioni-ID7557.html20%Monthly2017-10-17 13:19
http://www.dailyhealthindustry.it/brexit-la-lenta-fuga-dallisola-del-medtech-britannico-ID7554.html20%Monthly2017-10-17 13:10
http://www.dailyhealthindustry.it/biogen-da-aifa-luce-verde-a-spinraza-atrofia-muscolare-spinale-ID7550.html20%Monthly2017-10-16 15:25
http://www.dailyhealthindustry.it/johnson-ok-fda-per-stelara-negli-adolescenti-con-psoriasi-grave-ID7546.html20%Monthly2017-10-16 14:38
http://www.dailyhealthindustry.it/janssen-lancia-istep-piattaforma-mobile-per-il-paziente-ID7543.html20%Monthly2017-10-16 14:23
http://www.dailyhealthindustry.it/pharma-usa-gli-spot-tv-resistono-a-settembre-spesi-140-mln-di-dollari-ID7540.html20%Monthly2017-10-16 16:17
http://www.dailyhealthindustry.it/terapia-cart-algoritmo-individua-potenziali-sindromi-avverse-ID7536.html20%Monthly2017-10-16 12:30
http://www.dailyhealthindustry.it/roche-chmp-raccomanda-alecensa-tumore-al-polmone-ID7534.html20%Monthly2017-10-16 11:32
http://www.dailyhealthindustry.it/nih-collaborazione-con-11-pharma-per-accelerare-ricerca-immunoncologici-ID7531.html20%Monthly2017-10-13 15:38
http://www.dailyhealthindustry.it/spark-panel-fda-vota-allunanimita-per-luxturna-terapia-genica-cecita-ID7528.html20%Monthly2017-10-13 15:14
http://www.dailyhealthindustry.it/ebola-nejm-bene-i-test-dei-due-candidati-vaccini-uno-e-italiano-ID7526.html20%Monthly2017-10-13 14:54
http://www.dailyhealthindustry.it/bayer-per-stivarga-ce-lok-del-nice-ID7524.html20%Monthly2017-10-13 13:59
http://www.dailyhealthindustry.it/sanofi-punta-sul-vaccino-vaxigrip-tetra-nuovo-stabilimento-in-francia-ID7520.html20%Monthly2017-10-13 13:46
http://www.dailyhealthindustry.it/novartis-niente-cessione-azioni-a-roche-un-no-da-14-miliardi-di-dollari-ID7517.html20%Monthly2017-10-13 13:22
http://www.dailyhealthindustry.it/flexion-fundraising-in-borsa-per-lanciare-zilretta-artrite-ginocchio-ID7514.html20%Monthly2017-10-12 16:34
http://www.dailyhealthindustry.it/biogen-guida-studio-che-personalizza-rischio-pml-per-chi-assume-natalizumab-ID7512.html20%Monthly2017-10-12 16:21
http://www.dailyhealthindustry.it/obamacare-la-spallata-di-trump-rischia-di-andare-a-vuoto-ID7507.html20%Monthly2017-10-12 16:06
http://www.dailyhealthindustry.it/lincertezza-usa-si-riflette-sulla-filiera-e-il-packaging-e-il-primo-a-pagare-ID7504.html20%Monthly2017-10-12 15:13
http://www.dailyhealthindustry.it/milano-sede-ema-seconda-tappa-road-map-a-lubiana-ID7502.html20%Monthly2017-10-12 14:15
http://www.dailyhealthindustry.it/advertising-i-flag-sul-prodotto-aumentano-la-fiducia-del-paziente-e-la-argumet-dilution-ID7500.html20%Monthly2017-10-12 14:02
http://www.dailyhealthindustry.it/trump-mossa-solitaria-per-distruggere-lobamacare-ID7495.html20%Monthly2017-10-11 15:56
http://www.dailyhealthindustry.it/pfizer-nel-2018-vendita-della-bu-consumer-healthcare-ID7490.html20%Monthly2017-10-11 16:59
http://www.dailyhealthindustry.it/mylan-biocon-fda-chiede-chiarimenti-su-biosimilare-di-neulasta-amgen-ID7487.html20%Monthly2017-10-11 14:06
http://www.dailyhealthindustry.it/fda-gottlieb-smentisce-voci-di-addio-ID7484.html20%Monthly2017-10-11 12:46
http://www.dailyhealthindustry.it/pfizer-per-lafrica-con-american-cancer-society-e-clinton-health-initative-ID7482.html20%Monthly2017-10-11 16:21
http://www.dailyhealthindustry.it/spark-fda-decide-su-prima-terapia-genica-per-la-cecita-ID7478.html20%Monthly2017-10-11 10:31
http://www.dailyhealthindustry.it/milano-sede-ema-parte-da-bucarest-il-roadshow-diplomatico-ID7472.html20%Monthly2017-10-10 16:00
http://www.dailyhealthindustry.it/ema-aggiorna-linee-guida-su-etichettatura-eccipienti-medicinali-ID7470.html20%Monthly2017-10-10 16:35
http://www.dailyhealthindustry.it/malattie-rare-rhythm-si-quota-in-borsa-e-raccoglie-120-mln-di-dollari-ID7467.html20%Monthly2017-10-10 16:36
http://www.dailyhealthindustry.it/guerre-cyber-attacchi-contenziosi-tre-motivi-per-non-investire-nel-pharma-e-nel-biotech-ID7464.html20%Monthly2017-10-10 14:18
http://www.dailyhealthindustry.it/zoetis-nasce-primo-campo-macerie-coperto-ditalia-ID7461.html20%Monthly2017-10-10 13:24
http://www.dailyhealthindustry.it/novo-nordisk-in-usa-petizione-pubblica-per-difendere-victoza-dai-generici-ID7459.html20%Monthly2017-10-10 12:12
http://www.dailyhealthindustry.it/johnson-in-europa-punta-sul-biologico-350-mln-per-ampliare-il-sito-irlandese-ID7455.html20%Monthly2017-10-10 16:03
http://www.dailyhealthindustry.it/flexion-ok-fda-a-farmaco-non-oppioide-per-dolore-al-ginocchio-ID7453.html20%Monthly2017-10-09 16:27
http://www.dailyhealthindustry.it/distribuzione-farmaci-e-lora-di-amazon-ID7450.html20%Monthly2017-10-09 15:28
http://www.dailyhealthindustry.it/takeda-niente-brexit-fear-100-mln-di-euro-per-stabilimento-a-dublino-ID7447.html20%Monthly2017-10-09 14:53
http://www.dailyhealthindustry.it/farmaceutica-italia-funziona-la-produzione-conto-terzi-ID7445.html20%Monthly2017-10-09 13:45
http://www.dailyhealthindustry.it/biotech-medical-device-start-up-i-fondi-statali-puntano-sullhealth-economy-ID7443.html20%Monthly2017-10-09 12:49
http://www.dailyhealthindustry.it/bayer-johnson-xarelto-fallisce-trial-per-seconda-indicazione-ma-la-pharma-tedesca-e-ottimista-ID7439.html20%Monthly2017-10-09 11:37
http://www.dailyhealthindustry.it/brevetti-il-caso-allergan-scuote-il-congresso-usa-ID7437.html20%Monthly2017-10-06 16:18
http://www.dailyhealthindustry.it/nuova-tegola-per-teva-e-sempre-da-copaxone-ID7435.html20%Monthly2017-10-06 14:46
http://www.dailyhealthindustry.it/se-la-pharma-fa-home-made-advertising-il-caso-eli-lilly-ID7433.html20%Monthly2017-10-06 14:20
http://www.dailyhealthindustry.it/dynavax-cercasi-partner-per-lancio-vaccino-heplisav-epatite-b-ID7431.html20%Monthly2017-10-06 11:07
http://www.dailyhealthindustry.it/eli-lilly-respinge-lassalto-al-brevetto-di-alimta-pemetrexed-ID7429.html20%Monthly2017-10-06 10:43
http://www.dailyhealthindustry.it/gilead-bictegravir-a-basso-costo-nei-paesi-poveri-in-attesa-di-entrare-nei-mercati-usa-e-europa-ID7425.html20%Monthly2017-10-06 10:25
http://www.dailyhealthindustry.it/washington-e-new-delhi-braccio-di-ferro-per-taglio-prezzi-medical-devices-nel-mercato-indiano-ID7422.html20%Monthly2017-10-05 16:12
http://www.dailyhealthindustry.it/cantone-anac-approccio-scandalistico-alla-corruzione-in-sanita-ID7419.html20%Monthly2017-10-05 16:01
http://www.dailyhealthindustry.it/allergan-da-fda-terza-indicazione-per-botox-in-medicina-estetica-ok-per-le-rughe-sulla-fronte-ID7417.html20%Monthly2017-10-05 14:56
http://www.dailyhealthindustry.it/mylan-fda-da-via-libera-a-generico-copaxone-e-teva-protesta-ID7413.html20%Monthly2017-10-05 14:07
http://www.dailyhealthindustry.it/ge-healthcare-a-uppsala-primo-laboratorio-di-stampa-3-d-per-i-medical-device-ID7411.html20%Monthly2017-10-05 13:44
http://www.dailyhealthindustry.it/sede-ema-milano-bene-per-le-infrastrutture-ma-in-pole-position-ce-vienna-ID7409.html20%Monthly2017-10-05 16:57
http://www.dailyhealthindustry.it/vaccitech-il-primo-vaccino-universale-contro-linfluenza-arriva-alla-fase-due-ID7405.html20%Monthly2017-10-04 16:11
http://www.dailyhealthindustry.it/ema-rasi-ripercussioni-sui-farmaci-innovativi-se-si-sbaglia-scelta-nuova-sede-ID7403.html20%Monthly2017-10-04 14:18
http://www.dailyhealthindustry.it/celgene-punta-sugli-inibitori-tyk2-accordo-con-nimbus-ID7401.html20%Monthly2017-10-04 13:11
http://www.dailyhealthindustry.it/assobiomedica-massimiliano-boggetti-nuovo-presidente-intervista-esclusiva-ID7398.html20%Monthly2017-10-04 12:36
http://www.dailyhealthindustry.it/amgen-partnership-con-immatics-per-ricerca-cellule-t-ID7395.html20%Monthly2017-10-04 10:26
http://www.dailyhealthindustry.it/allergan-saunders-spiega-il-tribal-marketing-per-difendere-i-brevetti-ID7393.html20%Monthly2017-10-04 10:44
http://www.dailyhealthindustry.it/lorenzin-farmaci-innovativi-accessibili-a-tutti-ID7390.html20%Monthly2017-10-03 16:52
http://www.dailyhealthindustry.it/aaa-italia-ce-approva-radiofarmaco-per-tumori-net-ID7387.html20%Monthly2017-10-03 16:31
http://www.dailyhealthindustry.it/ema-prove-di-dialogo-sullhta-con-gli-stakeholder-ID7384.html20%Monthly2017-10-03 15:56
http://www.dailyhealthindustry.it/7379-ID7379.html20%Monthly2017-10-03 17:54
http://www.dailyhealthindustry.it/sanofi-un-advisory-board-per-studiare-il-comportamento-dei-pazienti-ID7377.html20%Monthly2017-10-03 15:26
http://www.dailyhealthindustry.it/sede-ema-ecco-le-tappe-verso-il-d-day-ID7374.html20%Monthly2017-10-03 10:27
http://www.dailyhealthindustry.it/farmaci-usa-pressioni-per-ridurre-prezzo-zinbryta-biogen-ID7370.html20%Monthly2017-10-02 17:09
http://www.dailyhealthindustry.it/nobel-2017-in-medicina-vince-lo-studio-del-ritmo-circadiano-ID7367.html20%Monthly2017-10-02 16:18
http://www.dailyhealthindustry.it/dynavax-studia-partnership-per-il-lancio-di-heplisav-vaccino-epatite-b-ID7365.html20%Monthly2017-10-02 14:54
http://www.dailyhealthindustry.it/governo-usa-170-mln-di-dollari-per-sviluppo-farmaci-e-vaccini-contro-ebola-ID7362.html20%Monthly2017-10-02 14:29
http://www.dailyhealthindustry.it/novo-nordisk-ok-fda-allinsulina-ultrarapida-fiasp-ID7360.html20%Monthly2017-10-02 17:42
http://www.dailyhealthindustry.it/bavarian-nordic-gli-usa-ordinano-13-milioni-di-dosi-imvamune-vaccino-vaiolo-ID7357.html20%Monthly2017-10-02 10:50